"The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic weight management in addition to a reduced-calorie diet and physical act"...
(Generic versions may still be available.)
Redux (dexfenfluramine hydrochloride capsules), an anti-obesity drug, is a serotonin reuptake inhibitor and releasing agent. Redux (dexfenfluramine fda removed from us market 9/15/97) is available for oral administration in white, opaque, hard-gelatin capsules. The active ingredient is dexfenfluramine hydrochloride. Each capsule contains 15 mg dexfenfluramine hydrochloride. Inactive ingredients include: lactose, gelatin capsule, corn starch, microcrystalline cellulose, talc, titanium dioxide, magnesium stearate, colloidal silicon dioxide, and edible ink.
Dexfenfluramine hydrochloride, a white to off-white crystalline powder, is designated chemically as (S)-N-ethyl-alpha-methyl-3-(trifluoromethyl) benzeneethanamine hydrochloride and has a molecular weight of 267.7. Its empirical formula is C12H16F3N·HCl. Dexfenfluramine is freely soluble in water, alcohol, chloroform, and methanol The pKa of dexfenfluramine hydrochloride is 10.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Redux Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.